血浆内皮微粒水平与2型糖尿病肾病的相关性分析
被引量:2
摘要
糖尿病肾病(DN)是导致终末期肾病(EsRD)的重要原因,尽管DN的发病机制尚未完全阐明,但糖尿病患者体内代谢紊乱、血流动力学异常等引起的内皮功能障碍是其高发微血管病变的病理生理基础^[1]。内皮功能障碍的评价对微血管并发症的防治有重要意义。
出处
《临床荟萃》
CAS
2012年第7期605-607,共3页
Clinical Focus
参考文献13
-
1Fomoni A,Ijaz A,Tejada T,et al.Role of inflammation in diabetic nephropathy[J].Curr Diabetes Rev,2008,4(1):10-17.
-
2Koga H,Sugiyama S,Kugiyama K,et al.Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type2diabetes mellitus and coronary artery disease[J].J Am Coll Cardiol,2005,45(10):1622-1630.
-
3Allen EM,Matthews JB,O’Connor R,et al.Periodontitis and type2diabetes:is oxidative stress the mechanistic link[J].Scott Med J,2009,54(2):41-47.
-
4Golderg RB.Cytokine and cytokine-like inflammation markers,endothelial dysfunction,and imbalanced coagulation in devdopment of diabetes and its complications[J].J Clin Endocrinol Metab,2009,94(9):3171-3182.
-
5Amabile N,Heiss C,Chang V,et al.Increased CD62e(+)endothelial microparticle levels predict poor outcome in pulmonary hypertension patients[J].Heart Lung Transplant,2009,28(10):1081-1086.
-
6Ayers L,Ferry B,Craig S,et al.Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea[J].Eur Respir J,2009,33(3):574-580.
-
7Huber J,Vales A,Mitulovic G,et al.Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions[J].Arterioscler Thromb Vasc Biol,2002,22(1):101-107.
-
8Angelot F,Seillès E,BiichléS,et al.Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation:potential implications in inflammatory diseases[J].Haematologica,2009,94(11):1502-1512.
-
9Chirinos JA,Zambrano JP,Virani SS,et al.Correlation between apoptotic endothelial microparticles and serum interleukin-6and C-reactive protein in healthy men[J].Am J Cardiol,2005,95(10):1258-1260.
-
10索丽霞,余叶蓉,喻红玲,王椿,唐红,陆志铭,张祥迅,王嘉南,赵桂芝.2型糖尿病患者胰岛素抵抗、血管内皮细胞功能与微量白蛋白尿[J].中华内分泌代谢杂志,2004,20(1):26-29. 被引量:50
二级参考文献13
-
1廖岚,雷闽湘,陈慧玲,吴嘉,郭丽娟.高敏C-反应蛋白与2型糖尿病肾病[J].中南大学学报(医学版),2004,29(6):627-630. 被引量:16
-
2张永,罗昌霞,张建鄂,李涛.来氟米特活性代谢产物对肿瘤坏死因子-α诱导肾小管上皮细胞内核因子-κB活性的影响[J].微循环学杂志,2006,16(2):18-20. 被引量:8
-
3陈景,赵劲,陈阳勤.血清炎症相关因子CRP与2型糖尿病肾病的关系探讨[J].南华大学学报(医学版),2007,35(3):386-388. 被引量:5
-
4Saraheimo M,Teppo AM, Forsblom C, et al. Diabetic nephropathy is associated with low- grade inflammation in type 1 diabetic patients. Diabetologia,2003,46(10) :1402 1407.
-
5Yudkin JS, Stehouwer CD, Emeis J J, et al. C - reactive protein in healthy subjects- associations with obesity, insulin resistance and endothelial dysfunction: a potential role for cytokines origi-nating from adipose tissue. Arterioscler Thromb Vasc Biol, 1999,19(4) :972 - 978.
-
6Devaraj S, Xu DY,Jialal I. C minogen activator inhibitor - 1 reactive protein increases plasexpression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation, 2003, 107 ( 3 ) : 398 - 404.
-
7Miceli - Richard C, Dougados M. Leflunomide for the treatment for the treatment of rheumatoid arthritis. Expert Opin Phamlacother, 2003,4 (6) : 987 - 997.
-
8Grisar J, Aringer M, Koller MD, et al. Leflunomide inhibits transendothelial migration of peripheral blood mononuelear cells. Ann Rheum Dis, 2004,63 (12) : 1632 - 1637.
-
9Tuttle KR. Linking metabolism and immunology: diabetic nephropathy is an inflammatory Disease. J Am Soc Nephrol, 2005,16(6) : 1537 - 1538.
-
10Ota T,Takamura T,Ando H, et al. Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular maerophage recruitment in a rat model. Diabetologia, 2003,46 (6) :843 - 851.
共引文献54
-
1夏静芬.阿托伐他汀对2型糖尿病老年患者颈部动脉斑块的影响[J].安徽医学,2013,34(10):1529-1531. 被引量:3
-
2卢曙芳,沈建国.2型糖尿病患者微量白蛋白尿与脑梗塞关系的研究[J].临床内科杂志,2005,22(3):193-194. 被引量:5
-
3陈宁,肖方森,马其林.糖尿病脑梗塞的对比分析[J].福建医药杂志,2005,27(2):33-34.
-
4李俊.2型糖尿病心血管并发症发病机制的研究进展[J].现代诊断与治疗,2005,16(5):295-297. 被引量:6
-
5甘胜莲,李红梅.2型糖尿病患者胰岛素抵抗、脂代谢紊乱与冠心病的关系探讨[J].实用预防医学,2006,13(3):612-613.
-
6张征,郭发金,韩栋,吴明晓,李慧玲.高分辨率超声在检测糖尿病患者早期血管内皮功能中的应用[J].中华老年医学杂志,2006,25(8):574-576. 被引量:3
-
7蒲素,余叶蓉,喻红玲,唐红,张祥讯.雌激素对肥胖女性内皮依赖性血管舒张功能的保护作用[J].中国糖尿病杂志,2006,14(5):363-365. 被引量:3
-
8张慧芹,项岫秀,俞芳,李伟娟,刘秀玲,肖红珍,刘阁玲.微量白蛋白尿与2型糖尿病下肢血管病变的关系[J].中国综合临床,2007,23(1):30-31. 被引量:3
-
9张彩云,冯卫.超声评价糖尿病患者外周动脉病变与血管内皮舒张功能的关系[J].中国医药导刊,2007,9(5):382-384. 被引量:2
-
10崔娟,姜刚书.糖尿病肾病的诊治现状[J].医学综述,2007,13(19):1503-1504. 被引量:6
同被引文献42
-
1宁雪梅,王艳杰.糖尿病患者细胞免疫功能的变化[J].实用心脑肺血管病杂志,2008,16(5):17-18. 被引量:5
-
2蔡文玮,朱健.老年糖尿病患者细胞免疫功能的观察[J].中国老年学杂志,2005,25(2):198-199. 被引量:4
-
3Mallone R, Martinuzzi E, Blancou P, et al. CD8^+ T-cell re- sponses identify beta-cell autoimmunity in human type 1 diabetes[J]. Diabetes, 2007,56 (3) : 613-621.
-
4Zykova SN,Svartberg J, Seljelid R, et al. Release of TNF-alpha from in vitro-stimulated monocytes is negatively associated with serum levels of apoliprotein B in patients with type 2 diabetes[J]. Seand J Iumunol, 2010,60 (5) : 535-542.
-
5Gupta D, Varma S,Khandelwal RL. Long-term effect of tumor necrosis factor-alpha treatment on insulin signaling pathway inHepG2 cells and HepG2 cells over expressing constitutively activeAkt/PKB[J]. J Cell Biochem, 2007,100(3) : 593-607.
-
6Thewissen M,Somesr V, Hellings N,et al. CD4^+ CD28 null T cells in autoimmune disease: pathogeic features and decreased susceptibility to immunoregulation [J]. J Imunol, 2007, 179 (10) :6514-6523.
-
7Sumi A,Yamanaka-Hanada N,Bai F,et al.Roles of coagulation pathway and factor Xa in the progression of diabetic nephropathy in db/db mice[J].Biological and Pharmaceutical Bulletin,2011,34(6):824-830.
-
8Ossovskaya V S,Bunnett N W.Protease-activated receptors:contribution to physiology and disease[J].Physiological reviews,2004,84(2):579-621.
-
9Macfarlane S R,Seatter M J,Kanke T,et al.Proteinase-activated receptors[J].Pharmacological reviews,2001,53(2):245-282.
-
10Border W A,Noble N A.TGF-beta in kidney fibrosis:a target for gene therapy[J].Kidney international,1997,51(5):1388.
引证文献2
-
1陈超.老年糖尿病患者淋巴细胞亚群变化[J].临床荟萃,2014,29(8):932-933. 被引量:1
-
2于牧鑫,马瑞爽,司宇,吴晓明,邓瑞娟,张妍,史文杰,解汝娟.糖尿病肾病致凝血异常的研究[J].现代生物医学进展,2015,15(19):3784-3785. 被引量:10
二级引证文献11
-
1王彦丽,郝礼森,张铁强,赵立军,柴丽丽.非酒精性脂肪性肝病患者外周血CD4^+CD25^+T细胞变化特点[J].热带医学杂志,2018,18(11):1462-1465. 被引量:3
-
2王峥,李建鹏.益肾活血方对糖尿病肾病患者(气阴两虚兼瘀血)凝血功能、血浆内皮素-1及降钙素基因相关肽的影响[J].中华中医药学刊,2017,35(5):1232-1235. 被引量:18
-
3陈士卉,陈光艳,纪书成.血必净注射液对糖尿病肾病患者凝血纤溶系统及血管内皮功能的影响[J].重庆医学,2017,46(19):2707-2710. 被引量:14
-
4苏惠娟,陈永强,李红帅,钱莹.血必净注射液对糖尿病肾病患者凝血纤溶系统及血管内皮功能指标的影响[J].安徽医学,2018,39(5):602-605. 被引量:17
-
5庄扬名,栗明.复荣通脉胶囊联合西医治疗气阴两虚夹瘀型糖尿病肾病Ⅲ、Ⅳ期疗效及对凝血功能和血管内皮细胞功能的影响[J].现代中西医结合杂志,2018,27(22):2465-2468. 被引量:10
-
6刘涛,冯雪,翟晓玲,高智,王建华.益气补肾方对早期糖尿病肾病患者血清hs-CRP、FIB、Cys C的影响[J].现代中西医结合杂志,2018,27(34):3813-3816. 被引量:4
-
7王安阳,刘蕾,李慧乔,王俊楠,邹静,万美燕.血栓弹力图与常规凝血参数在糖尿病肾病中的对比分析[J].中国中西医结合肾病杂志,2018,19(10):899-901. 被引量:6
-
8顾红静,冯胜刚.阿魏酸哌嗪对糖尿病肾病作用机制的研究进展[J].西部医学,2019,31(10):1637-1640. 被引量:8
-
9姜国英,陈德政,张勇,王明莉,唐小琰,彭李.早期糖尿病肾病患者血小板相关参数测定的临床意义[J].临床肾脏病杂志,2021,21(2):136-139. 被引量:3
-
10郭天扬,高峰.2型糖尿病肾病患者血浆TM、PIC、FIB、D-D水平及临床意义[J].糖尿病新世界,2023,26(10):14-17.
-
1向艳云,张木勋.糖尿病及糖尿病合并下肢血管病变者血浆内皮微粒的变化[J].临床内科杂志,2008,25(9):600-602. 被引量:4
-
2刘建辉,孙志平,王琴,王丽,姚璐.糖尿病肾病患者血浆EMP与AECA的诊断价值[J].热带医学杂志,2015,15(11):1478-1480. 被引量:7
-
3张欣,龙盼,张俊峰,王连升,魏冬,张田田,徐芒华.内皮微粒与冠心病相关性研究[J].临床心血管病杂志,2012,28(1):24-27. 被引量:1
-
4黄宇理,李妙男,徐玮,王洪巨.瑞舒伐他汀对老年急性冠脉综合征患者血浆内皮微粒的影响[J].中国老年学杂志,2015,35(8):2027-2028. 被引量:5
-
5刘建辉,孙志平,杜月菊,贾敏,白明晨,耿瑞丽,谢霞,郭文潮.系统性红斑狼疮患者血浆内皮微粒和狼疮抗凝物检测的意义[J].河北医药,2011,33(11):1610-1612. 被引量:6
-
6李妙男,王洪巨,黄宇理,张宁汝,唐碧,宣玲.老年原发性高血压合并代谢综合征患者血浆内皮微粒的变化[J].临床心血管病杂志,2015,31(3):310-313. 被引量:1
-
7谢倩倩,朱建兵,韦小未,周瑶瑶,张田田,张俊峰.PCI术后内皮微粒水平动态变化与AMI类型的关联性及其临床意义[J].心脏杂志,2015,27(1):16-19. 被引量:1
-
8王从军,陈梅,雷中劲.川崎病患儿血浆内皮微粒水平与冠状动脉病变的关系[J].细胞与分子免疫学杂志,2014,30(6):647-648. 被引量:3
-
9任智超,张子新,李烨,张钧伟.原发性高血压患者血压变异性、昼夜节律与内皮微粒水平的相关性[J].中华高血压杂志,2015,23(11):1045-1052. 被引量:12
-
10权晓慧,王聪霞,李毓杰,石昭昭,秦少博.内皮微粒CD31^+/CD42b^-水平、颈动脉内膜中层厚度与冠状动脉病变程度的相关性[J].中国老年学杂志,2016,36(11):2650-2652. 被引量:9